Table 2 Details of subsequent therapy among the whole cohort

Platinum-based chemotherapy

35

79.5

Paclitaxel + Platinum

16

36.4

Albumin-bound Paclitaxel + Platinum

13

29.5

PLD + Platinum

6

13.6

Non-platinum-based chemotherapy

5

11.4

PLD

4

9.1

PLD + Albumin-bound Paclitaxel

1

2.3

Target therapy

2

4.5

Olaparib + Apatinib

1

2.3

Niraparib

1

2.3

Best supportive care

2

4.5

Cytoreduction surgery

Yes

12

27.3

No

32

72.7